Palomäki Antti, Kiviniemi Tuomas, Hartikainen Juha E K, Mustonen Pirjo, Ylitalo Antti, Nuotio Ilpo, Hartikainen Päivi, Jaakkola Jussi, Luite Riho, Airaksinen K E Juhani
Heart Center, Turku University Hospital and University of Turku, Turku, Finland.
Heart Center, Kuopio University Hospital, Kuopio, Finland.
Clin Cardiol. 2016 Aug;39(8):471-6. doi: 10.1002/clc.22554. Epub 2016 May 30.
Patients with atrial fibrillation (AF) frequently undergo invasive procedures. Optimal perioperative use of oral anticoagulation (OAC) and heparin bridging is not well defined.
Discontinuation of OAC for minor procedures/operations places AF patients at risk for thromboembolism.
In this study, we assessed perioperative antithrombotic treatment in patients with AF who suffered a postoperative stroke or intracranial bleeding. The FibStroke Study includes AF patients with an ischemic stroke or intracranial bleed identified from the discharge registries of 4 Finnish hospitals. In total, 3632 consecutive patients developed 3252 ischemic strokes and 794 intracranial bleeds. All invasive procedures during the 30 days preceding the stroke or intracranial bleed were identified.
A total of 194/3252 (6.0%) ischemic strokes and 23/794 (2.9%) intracranial bleeds were preceded by a procedure. Altogether, 69% of the patients were on OAC prior to index procedure, OAC was interrupted in 81.2% of the procedures preceding a stroke, and heparin bridging was used in 27.8% of interruptions. Of the procedures leading to stroke, 42.3% were low-bleeding-risk procedures, and OAC was interrupted in 84.7% of these procedures. The median time from procedure to stroke was 4 days. Heparin bridging was used in 54.5% of OAC interruptions preceding intracranial bleeding and combination of anticoagulation with antiplatelet therapy by 43.5% of patients with postoperative intracranial bleeding.
Perioperative interruption of OAC is common in patients who suffer a postoperative stroke, even in patients with low-bleeding-risk procedures. Postoperative intracranial bleeding is frequently preceded by perioperative heparin bridging.
心房颤动(AF)患者经常接受侵入性手术。口服抗凝药(OAC)和肝素桥接在围手术期的最佳使用尚未明确界定。
因小型手术/操作而停用OAC会使AF患者面临血栓栓塞风险。
在本研究中,我们评估了发生术后中风或颅内出血的AF患者的围手术期抗栓治疗。FibStroke研究纳入了从4家芬兰医院出院登记中识别出的患有缺血性中风或颅内出血的AF患者。总共3632例连续患者发生了3252例缺血性中风和794例颅内出血。确定了中风或颅内出血前30天内的所有侵入性手术。
共有194/3252例(6.0%)缺血性中风和23/794例(2.9%)颅内出血发生在手术之前。总体而言,69%的患者在索引手术前接受OAC治疗,在中风前的手术中,81.2%的手术中断了OAC,27.8%的中断使用了肝素桥接。在导致中风的手术中,42.3%为低出血风险手术,其中84.7%的手术中断了OAC。从手术到中风的中位时间为4天。颅内出血前OAC中断的情况中,54.5%使用了肝素桥接,术后颅内出血患者中有43.5%采用了抗凝与抗血小板治疗联合使用的方法。
术后中风患者围手术期中断OAC很常见,即使是低出血风险手术的患者也是如此。术后颅内出血之前经常进行围手术期肝素桥接。